Nu-Tek BioSciences is an innovative industrial ingredient manufacturer that supplied a critical component used in the manufacturing of the COVID-19 vaccine. After 10 successful years, DEED is supporting their new manufacturing facility in Austin, Minn.
Their expansion will create 35 new jobs and continue their portfolio of a wide range of projects from pharmaceuticals to fermentation nutrient systems.
Of the new facility, Thomas Yezzi, CEO of Nu-Tek said, “We’re pleased to expand our operations in the growing pharmaceutical industry. The core of our business is manufacturing and this investment underscores our commitment to the Austin community and building long-term businesses in the state of Minnesota.”